Part of your month, every month: R&Q Intelligence Series webinars are held on the fourth Tuesday of every month. These free webinars from some of the medical device industry's leading-most experts are designed for reporting on and analyzing the top industry trends and topics in the medical device space, each providing key and actionable takeaways for attendees. Slides and recordings will be made available to all registrants. Next up: May 23rd, where discuss MEDDEV 2.7.1 & CERs.

Medical Device Regulation Europe R&Q Intelligence Series

What? 

Please join us for a free R&Q Intelligence Series webinar:
EU MDR: Assessing the impact and next steps.

The session will be held on Tuesday, April 25th from 1:00pm - 2:00pm EST. The learning opportunity is free.

Know the essential EU MDR requirements.

The upcoming EU MDR changes are significant, potentially impacting your device classification and the need for clinical data. Considering the overall timeline – including ISO 13485:2016 (March 2019) and MDSAP (if selling in Canada; Jan. 2019) – it will be difficult to get on the notified bodies’ schedules.

The time to plan and act on these changes is now.

Your technical files, design dossiers, quality system documents, clinical plans, labeling (including UDI), software, and more will be affected. Plus new requirements are coming into play, including Eudamed and periodic safety update reports (PSURs).

This webinar will describe what to do now, what to keep your eye on, and real-world examples that show how industry is working through the changes. Interpretations will evolve, but our experts will be able to help you navigate the process.

What will be covered?

In addition to the background/history of EU MDR, the 'stacking effect' for Notified Bodies, and R&Q's proposed solution, the session will cover the key EU MDR changes:

  • Classification changes
  • Increased clinical evidence
  • Expert group consultations for higher risk devices
  • Increased scrutiny of technical documentation
  • Supply chain controls
  • Emphasis on control of reprocessing and reuse of devices
  • “Responsible Person”
  • Common specifications
  • Trending and PMS
  • State of the art assessments
  • Eudamed database
  • Unique Device Identification (UDI)
  • General safety and performance requirements
  • Unannounced audits
  • What to do: R&Q recommended next steps

Key takeaways

  • Learn the essential EU MDR requirements
  • Know how it might impact my company
  • Understand immediate actions and potential next steps
  • Practical tips and guidance for implementation
  • Valuable insight from experienced industry leaders

Who should attend?

This session is designed for medical device manufacturers who market in the EU.

Also, newly appointed medical device companies in areas of cosmetics, cosmetic lights/lasers, colored contact lenses, cleaning and disinfecting solutions, sub-dermal and trans-dermal implants are a good fit for this session.

Appropriate job functions include:

  • C-Level Executives
  • RA/QA Directors
  • Quality Managers
  • Regulatory Affairs Managers
  • Regulatory Specialists
  • Quality Specialists
  • Quality Engineers

We are passionate about your success. Tell us more about your regulatory and quality needs so we can help.

Book a Consultation

GLOBAL BOTTOM CTA INSTRUCTIONS:

To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!